Prelude Therapeutics Incorporated · NASDAQ:PRLD
Orbimed Advisors LLC reported a 16.00% stake in Prelude Therapeutics Incorporated (Schedule 13D/A)
Event Apr 21, 2026 · Filed Apr 23, 2026
Orbimed Advisors LLC reported a 16.00% stake in Prelude Therapeutics Incorporated, 12,935,071 shares, with active intent on Apr 21, 2026. Filed Apr 23, 2026 (Schedule 13D/A).
- Stake
- 16.00%
- Shares
- 12,935,071
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 16.00% | 12,935,071 |
| ORBIMED CAPITAL GP VI LLC | 14.60% | 11,808,945 |
| OrbiMed Genesis GP LLC | 1.40% | 1,126,126 |
| ORBIMED CAPITAL LLC | 1.00% | 789,500 |
Source
Related
- Prelude Therapeutics Incorporated
- Orbimed Advisors LLC
- Prelude Therapeutics Incorporated shareholders
- Schedule 13G · Soleus Capital Management, L.P. · Jul 8, 2026
- Form 4 · Shah Rajeev M. · Apr 28, 2026
- Schedule 13G · Ra Capital Management, L.P. · Apr 28, 2026
- Form 4 · Bonita David P · Apr 23, 2026
- Form 4 · OrbiMed Genesis GP LLC · Apr 23, 2026